- Home
- AMPX vs LXRX Comparison
AMPX vs LXRX Comparison
Compare AMPX & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPX
- LXRX
- Stock Information
- Founded
- AMPX 2008
- LXRX 1995
- Country
- AMPX United States
- LXRX United States
- Employees
- AMPX N/A
- LXRX N/A
- Industry
- AMPX Industrial Machinery/Components
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMPX Miscellaneous
- LXRX Health Care
- Exchange
- AMPX Nasdaq
- LXRX Nasdaq
- Market Cap
- AMPX 261.6M
- LXRX 228.8M
- IPO Year
- AMPX N/A
- LXRX 2000
- Fundamental
- Price
- AMPX $3.92
- LXRX $0.89
- Analyst Decision
- AMPX Strong Buy
- LXRX Buy
- Analyst Count
- AMPX 7
- LXRX 4
- Target Price
- AMPX $8.71
- LXRX $3.67
- AVG Volume (30 Days)
- AMPX 5.5M
- LXRX 5.3M
- Earning Date
- AMPX 08-07-2025
- LXRX 07-31-2025
- Dividend Yield
- AMPX N/A
- LXRX N/A
- EPS Growth
- AMPX N/A
- LXRX N/A
- EPS
- AMPX N/A
- LXRX N/A
- Revenue
- AMPX $33,115,000.00
- LXRX $31,213,000.00
- Revenue This Year
- AMPX $167.22
- LXRX N/A
- Revenue Next Year
- AMPX $208.02
- LXRX N/A
- P/E Ratio
- AMPX N/A
- LXRX N/A
- Revenue Growth
- AMPX 209.20
- LXRX 1251.21
- 52 Week Low
- AMPX $0.61
- LXRX $0.28
- 52 Week High
- AMPX $4.35
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- AMPX 61.92
- LXRX 63.27
- Support Level
- AMPX $2.55
- LXRX $0.80
- Resistance Level
- AMPX $4.35
- LXRX $0.96
- Average True Range (ATR)
- AMPX 0.35
- LXRX 0.07
- MACD
- AMPX 0.03
- LXRX 0.02
- Stochastic Oscillator
- AMPX 77.15
- LXRX 81.52
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.